Fig. 2b: Proposed pharmacological treatment for subjects on GC treatment and/or GCOP; modified from the ACR guidelines [225]; AL: alendronate, RIS: risedronate, ZA: zoledronic acid, TER: teriparatide, Rx: treatment, mos: months, *: based on a single randomized clinical trial, **: based on consensus, ?: no consensus